Tumor Marker Index Based on CEA and CA19-9 as a Prognostic Biomarker in Resectable Colon Cancer

Cancer Diagnosis and Prognosis · Published 2026-07-01 · DOI 10.21873/cdp.10572

Free full text

Authors (10)

TATSUFUMI KOSUGE, JUNICHI MAZAKI, KENTA KASAHARA, HIROAKI OSAKABE, HIROSHI KUWABARA, KENICHI IWASAKI, JUNYA OGUMA, HIROYUKI KOGA, AKISHIGE KANAZAWA, YUICHI NAGAKAWA

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

KOSUGE, T., MAZAKI, J., KASAHARA, K., et al. (2026). Tumor Marker Index Based on CEA and CA19-9 as a Prognostic Biomarker in Resectable Colon Cancer. Cancer Diagnosis and Prognosis. https://doi.org/10.21873/cdp.10572

Related articles

• Development of Second Primary Malignancies in Long- term Survivors of Unresectable Esophageal Cancer · Cancer Diagnosis and Prognosis · 2026 · Same journal
• Prognosis Using Modified Albumin–Bilirubin Grade in Resected Biliary Tract Cancer: A Multicenter Propensity Score–matched Analysis · Cancer Diagnosis and Prognosis · 2026 · Same journal
• The Combination of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 and Recombinant Methioninase Is Not Cancer-selective in a Co-culture Model of Colon Cancer Cells and Normal Fibroblasts · Cancer Diagnosis and Prognosis · 2026 · Same journal
• Diagnostic Challenge of a Tumor-mimicking Spinal Pseudogout Lesion: Case Report and Literature Review · Cancer Diagnosis and Prognosis · 2026 · Same journal
• The Relationship Between Vascular Endothelial Growth Factor Expression in T Cell Subsets and Survival of Patients With Colorectal Cancer · Cancer Diagnosis and Prognosis · 2026 · Same journal
• A Case of Hyalinizing Clear-cell Carcinoma With EWSR1–ATF1 Fusion Gene Arising From the Minor Salivary Gland of the Tongue · Cancer Diagnosis and Prognosis · 2026 · Same journal
• BCR::ABL1 Mutational Profiling in US Patients With Chronic-phase Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitors · Cancer Diagnosis and Prognosis · 2026 · Same journal
• Pre-treatment NLR and Changes in NLR Are Associated With Survival Following the Initiation of Immune Checkpoint Inhibitor Therapy in Patients With Non-small Cell Lung Cancer · Cancer Diagnosis and Prognosis · 2026 · Same journal
• Ocular Adnexal Lymphoma: An Ophthalmologist’s Perspective from a Single-center Experience · Cancer Diagnosis and Prognosis · 2026 · Same journal
• Prognostic Nutritional Index Predicts Early Recurrence After Esophagectomy for Esophageal Cancer Following Neoadjuvant Chemotherapy · Cancer Diagnosis and Prognosis · 2026 · Same journal